Biomarker analysis shows a trend towards lower IFIT3 and Foxp3 expression in patients with pulmonary metastases but did not reach statistical significance most likely because of small patient numbers.
1
—
—
Biomarker analysis shows a trend towards lower IFIT3 and Foxp3 expression in patients with pulmonary metastases but did not reach statistical significance most likely because of small patient numbers.